Leading Companies in Japan Gabapentin Market | Key Industry Leaders 2026

Leading Companies in Japan Gabapentin Market

Japan gabapentin market is marked by a strong shift toward generic cost-containment and the growing dominance of localized "Value-Added Generics." While global originators have traditionally led the business, it is currently dominated by domestic generic giants such as Sawai Pharmaceutical and Nichi-Iko, as well as specialist innovators such as Daiichi Sankyo.

Japan Gabapentin Market Overview

According to 6Wresearch, the Japan gabapentin market is projected for steady growth, fueled by Japan’s status as one of the world's most aged societies, leading to a high prevalence of chronic neurological conditions. The market is currently experiencing a transition where the tablet segment is registering the fastest growth, surpassing traditional capsules due to their ease of administration for elderly patients. This transition is driven by the improvement of "OD" (Orally Disintegrating) tablet technology and the use of automated dispensing systems in Japanese pharmacies.

Competitive Landscape

The competitive landscape in Japan is a strategic blend of multinational pharmaceutical firms and agile domestic generic manufacturers. Leading companies hold a significant market share by securing listings in the National Health Insurance (NHI) price list and maintaining robust supply chains. To meet the growing professional demand for safer pain management, they also make significant investments in R&D to develop proprietary gabapentinoid formulations, such as Tarlige (mirogabalin).

Below is a list of leading players operating in the Japan Gabapentin Market:

1. Pfizer Inc.

As the original patent holder for Neurontin, Pfizer remains a key player in the branded segment, leveraging deep clinical credibility among Japanese neurologists.

2. Sawai Pharmaceutical Co., Ltd.

Japan’s leading generic manufacturer, specializing in "Value-Added Generics" that modify tablet size and flavor to enhance patient adherence.

3. Nichi-Iko Pharmaceutical Co., Ltd.

A major domestic producer with high-volume manufacturing capabilities for gabapentin tablets and capsules, focusing on stable supply to hospital pharmacies.

4. Daiichi Sankyo Company, Limited

While focusing on oncology, their development of Tarlige (a next-gen gabapentinoid) has redefined the neuropathic pain market standards in Japan.

5. Viatris Inc.

Operates a massive portfolio of off-patent medications in Japan, providing high-quality generic gabapentin under a globally recognized brand.

6. Teva Takeda Pharma Ltd.

A strategic partnership between Teva and Takeda that dominates the generic channel by combining global R&D with a vast domestic distribution network.

7. Meiji Seika Pharma Co., Ltd.

A trusted name in infectious diseases and CNS disorders, providing specialized anti-epileptic and analgesic formulations to the Japanese market.

8. Kyowa Kirin Co., Ltd.

Focuses on specialty medicine and CNS therapies, contributing to the development of integrated pain management protocols.

9. Sun Pharma Ltd.

The Japanese arm of the global generic giant, focusing on providing affordable chronic pain therapies through localized manufacturing partnerships.

10. Eisai Co., Ltd.

A leader in neurology, Eisai provides comprehensive support for epilepsy and neuropathic pain patients through its extensive network of medical representatives.

11. Novartis Pharma K.K.

Known for its Sandoz generic division (now independent but highly active in Japan), it remains a critical supplier of gabapentin capsules.

12. Apotex Inc.

Supplies a significant volume of generic gabapentin API and finished dosages to the Japanese retail pharmacy sector.

13. Ohara Pharmaceutical Co., Ltd.

A specialized player focused on orphan drugs and high-quality generics for the elderly, including customized neurological formulations.

14. Towa Pharmaceutical Co., Ltd.

Renowned for its "RACTAB" technology, which produces rapidly disintegrating tablets that are highly favored in Japanese nursing homes.

15. Zydus Lifesciences

Leverages cost-effective manufacturing to supply high-purity gabapentin API to Japanese domestic formulation partners.

Leading Companies in Japan Gabapentin Market: FAQs